Andrea T Hooper Selected Research

Andrea T Hooper Research Topics

Disease

19	Neoplasms (Cancer) 01/2022 - 05/2002
10	COVID-19 10/2022 - 01/2021
3	Asymptomatic Infections 01/2022 - 01/2021
3	Breast Neoplasms (Breast Cancer) 10/2006 - 12/2003
2	Infections 06/2021 - 01/2021
2	Carcinoma (Carcinomatosis) 04/2010 - 05/2002
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 03/2010 - 09/2009
2	Neoplasm Metastasis (Metastasis) 09/2008 - 06/2002
2	Adenocarcinoma 06/2008 - 08/2004
1	Hypophosphatemia 01/2022
1	Hypersensitivity (Allergy) 01/2021
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Myocarditis (Carditis) 01/2019
1	Diabetes Mellitus 01/2013
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 04/2010
1	Cystitis 04/2010
1	Urinary Bladder Neoplasms (Bladder Cancer) 04/2010
1	Cytopenia 09/2009
1	Vascular Remodeling 07/2009
1	Melanoma (Melanoma, Malignant) 09/2008
1	Carcinogenesis 06/2008
1	Inflammation (Inflammations) 06/2008
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2008
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2007
1	Sarcoma (Soft Tissue Sarcoma) 03/2007
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2006
1	Hyperplasia 10/2006
1	Burkitt Lymphoma (Burkitt's Lymphoma) 10/2006
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2006
1	Lymphoma (Lymphomas) 10/2006
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2006
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2006
1	Hypopigmentation (Hypomelanosis) 02/2006
1	Neutropenia 07/2005
1	Multiple Myeloma 04/2005

Drug/Important Bio-Agent (IBA)

10	Monoclonal AntibodiesIBA 10/2022 - 05/2002
9	casirivimab and imdevimab drug combinationIBA 10/2022 - 01/2021
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2007
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2009 - 06/2002
4	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2008 - 06/2002
4	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 09/2008 - 06/2002
4	LigandsIBA 03/2007 - 12/2003
3	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 10/2006 - 04/2005
2	Cadherins (E-Cadherin)IBA 01/2022 - 01/2018
2	PF-06671008IBA 01/2022 - 01/2018
2	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 08/2011
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2021 - 03/2007
2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2019
2	Antineoplastic Agents (Antineoplastics)IBA 08/2011 - 03/2007
2	CytokinesIBA 03/2010 - 12/2008
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2007 - 06/2002
2	Mitogen-Activated Protein KinasesIBA 10/2006 - 12/2003
2	DNA (Deoxyribonucleic Acid)IBA 02/2006 - 08/2004
1	COVID-19 VaccinesIBA 10/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Extracellular Matrix ProteinsIBA 01/2022
1	Cell Adhesion MoleculesIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Fibronectins (Fibronectin)IBA 01/2022
1	auristatinIBA 01/2022
1	Histones (Histone)IBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 09/2021
1	Neutralizing AntibodiesIBA 01/2021
1	CD3 ComplexIBA 01/2018
1	Metformin (Glucophage)FDA LinkGeneric 02/2014
1	Adenosine Triphosphate (ATP)IBA 02/2014
1	Glucose (Dextrose)FDA LinkGeneric 02/2014
1	Glutathione (Reduced Glutathione)IBA 02/2014
1	NADP (NADPH)IBA 02/2014
1	Lactic Acid (Lactate)FDA LinkGeneric 02/2014
1	Monocarboxylic Acid TransportersIBA 02/2014
1	erucylphosphocholineIBA 01/2013
1	CEACAM1 ProteinIBA 04/2010
1	ImmunosorbentsIBA 04/2010
1	EnzymesIBA 04/2010
1	N 30IBA 04/2010
1	human FLT4 proteinIBA 09/2009
1	Carrier Proteins (Binding Protein)IBA 07/2009
1	tumor-derived adhesion factorIBA 07/2009
1	Differentiation AntigensIBA 09/2008
1	DC101 monoclonal antibodyIBA 09/2008
1	Epithelial Cell Adhesion MoleculeIBA 06/2008
1	Interleukin-10 (Interleukin 10)IBA 06/2008
1	CaspasesIBA 02/2008
1	macrophage stimulating proteinIBA 03/2007
1	Messenger RNA (mRNA)IBA 03/2007
1	Small Interfering RNA (siRNA)IBA 03/2007
1	AngiopoietinsIBA 03/2007
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 04/2005
1	Interleukin-12 (IL 12)IBA 08/2004
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2003
1	Cell Surface ReceptorsIBA 12/2003
1	Insulin-Like PeptidesIBA 12/2003

Therapy/Procedure

9	Therapeutics 01/2022 - 05/2002
2	Drug Therapy (Chemotherapy) 08/2011 - 07/2005
1	Subcutaneous Injections 01/2021
1	Transplantation 03/2010
1	Immunotherapy 09/2008
1	Heterologous Transplantation (Xenotransplantation) 06/2008